The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Correlation of tumor mutational burden (TMB) with molecular profiling and clinical characteristics in patients with bladder cancer.
 
Divya Natesan
No Relationships to Disclose
 
Henry Martell
No Relationships to Disclose
 
Patrick Devine
No Relationships to Disclose
 
Bradley A. Stohr
No Relationships to Disclose
 
James P. Grenert
No Relationships to Disclose
 
Jessica Van Ziffle
No Relationships to Disclose
 
Nancy M. Joseph
Stock and Other Ownership Interests - ABION
 
Boris C. Bastian
No Relationships to Disclose
 
Sarah E Umetsu
No Relationships to Disclose
 
Courtney Onodera
No Relationships to Disclose
 
Emily Chan
Research Funding - Proscia (Inst)
 
Arpita Desai
No Relationships to Disclose
 
Anthony C. Wong
No Relationships to Disclose
 
Sima P. Porten
Honoraria - photocure
Consulting or Advisory Role - Bristol-Myers Squibb; KDx Diagnostics; Photocure
Research Funding - Photocure (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Jonathan Chou
Stock and Other Ownership Interests - Array BioPharma (I); Atara Biotherapeutics (I); Celgene (I)
 
Terence W. Friedlander
Leadership - Med BioGene
Honoraria - AstraZeneca/MedImmune; EMD Serono; Seattle Genetics/Astellas; Seattle Genetics/Astellas
Consulting or Advisory Role - Abbvie; Abbvie; AstraZeneca; Dava Oncology; Dendreon; Foundation Medicine; Janssen; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Incyte (Inst); Janssen; Neon Therapeutics (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - AstraZeneca/MedImmune; Genentech/Roche; Jounce Therapeutics
 
Eric Jay Small
Stock and Other Ownership Interests - Fortis; Harpoon Therapeutics
Honoraria - Janssen
Consulting or Advisory Role - Beigene; Fortis; Janssen Oncology; Teon Therapeutics; Tolero Pharmaceuticals
Research Funding - Janssen (Inst); Merck (Inst)
Travel, Accommodations, Expenses - Janssen
 
Lawrence Fong
Consulting or Advisory Role - Atreca; BioAtla; Bolt Biotherapeutics; Nutcracker Therapeutics, Inc.; TeneoBio
Research Funding - Abbvie (Inst); Bavarian Nordic (Inst); Bristol-Myers Squibb (Inst); Dendreon (Inst); Janssen Oncology (Inst); Merck (Inst); Roche/Genentech (Inst)
 
Eric Alejandro Sweet-Cordero
No Relationships to Disclose
 
Vadim S Koshkin
Consulting or Advisory Role - AstraZeneca; Dendreon; Janssen